Sheri Dubey
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, Viral Infections and Outbreaks Research, Viral Infections and Vectors, Immune Cell Function and Interaction, Herpesvirus Infections and Treatments
Most-Cited Works
- → Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity(2002)1,174 cited
- → Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination(2000)885 cited
- → HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis(2008)699 cited
- → Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene(2003)398 cited
- → Metabolic Phenotypes of Response to Vaccination in Humans(2017)279 cited
- → Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults(2008)243 cited
- → Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial(2011)227 cited
- → Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans(2009)133 cited
- → A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens(2015)119 cited
- → A replication-defective human cytomegalovirus vaccine for prevention of congenital infection(2016)106 cited